Mastek Allots 3,442 Equity Shares Under Employee Stock Option Plan VII, Paid-Up Capital Rises
Mastek allotted 3,442 equity shares of Rs. 5 each under ESOP Plan VII on May 8, 2026, to eligible employees who exercised their vested options. The allotment increased the company's paid-up share capital from Rs. 15,49,86,700 to Rs. 15,50,03,910, with total issued shares rising to 3,10,00,782. The shares were allotted across three exercise price tranches — Rs. 5, Rs. 174, and Rs. 350 per share — and rank pari-passu with existing equity shares with no lock-in restrictions.

*this image is generated using AI for illustrative purposes only.
The Stakeholder's Relationship Committee of the Board of Directors of mastek approved and allotted 3,442 equity shares of Rs. 5 each (face value) on May 8, 2026, under the company's Employee Stock Option Plan VII (ESOP Plan VII). The allotment was made to eligible employees who had exercised their vested stock options. The newly issued shares rank pari-passu with the existing equity shares of the company in all respects, with no lock-in restrictions applicable.
Impact on Paid-Up Share Capital
Consequent to this allotment, Mastek's paid-up share capital has increased as detailed below:
| Metric: | Before Allotment | After Allotment |
|---|---|---|
| Number of Equity Shares: | 3,09,97,340 | 3,10,00,782 |
| Face Value per Share: | Rs. 5 | Rs. 5 |
| Total Paid-Up Share Capital: | Rs. 15,49,86,700 | Rs. 15,50,03,910 |
ESOP Plan VII — Allotment Details
The allotment was made pursuant to ESOP Plan VII, for which in-principle listing approvals were received from BSE Limited on October 8, 2013, and from the National Stock Exchange of India Limited on September 16, 2013, each covering up to 25,00,000 equity shares of Rs. 5 each. The disclosure has been made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Regulation 10(c) of the SEBI (Share Based Employee Benefits) Regulations, 2014.
The key details of the allotment are summarised below:
| Parameter: | Details |
|---|---|
| Date of Issue: | May 8, 2026 |
| Number of Shares Issued: | 3,442 |
| Par Value per Share: | Rs. 5 |
| ESOP Plan: | ESOP Plan VII |
| Kind of Security: | Equity Shares |
| Distinctive Numbers: | 3,79,29,291 to 3,79,32,732 |
| Lock-In: | Not Applicable |
| Total Issued Shares After Issue: | 3,10,00,782 |
| Total Issued Share Capital After Issue: | Rs. 15,50,03,910 |
Exercise Price and Premium Breakdown
The 3,442 shares were allotted across three tranches with varying exercise prices and premiums, as disclosed by the company:
| No. of Equity Shares: | Exercise Price per Share (Rs.) | Premium per Share (Rs.) |
|---|---|---|
| 2,981 | 5 | 0 |
| 175 | 174 | 169 |
| 286 | 350 | 345 |
The disclosure was filed by Reena Raje, Company Secretary & Compliance Officer (Membership No. A21440), on behalf of Mastek. The company's registered office is located at 804/805, President House, Opp. C. N. Vidyalaya, Near Ambawadi Circle, Ahmedabad – 380 006, Gujarat.
Historical Stock Returns for Mastek
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.25% | -0.66% | +9.98% | -19.84% | -19.64% | -14.69% |
How might Mastek's continued ESOP allotments under Plan VII impact employee retention and talent acquisition strategies in the competitive IT services sector going forward?
Given that a majority of the allotted shares (2,981) were issued at face value with zero premium, what does this suggest about the vintage and structure of Mastek's older ESOP tranches, and could this dilution pattern accelerate in future quarters?
How will the gradual increase in Mastek's paid-up share capital through recurring ESOP exercises affect its earnings per share (EPS) metrics and valuation multiples over the next fiscal year?


































